螞蟻集團旗下芝麻信用推出全國首個中小企業立信平台
螞蟻集團公布,旗下芝麻信用推出全國首個中小企業立信平台,超過400萬中小企業成為平台首批入駐者。
集團表示,中小企業主可在平台上一站式查看企業在工商、司法等方面的公開信息,並可進一步填充信息,完成對自身信息管理、信用管理。
作為央行備案的企業徵信機構,芝麻信用的立信平台已與多個數據服務方達成合作。同時中國司法大數據研究院與芝麻信用達成戰略合作,作為最高人民法院黨組牽頭成立的企業製研究機構,其將通過立信平台,打造國內首個權威「司法服務專區」,解決過去企業查詢公開案件信息時所遇到的來源不穩定、內容缺失、信息滯後等問題。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.